Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.13 -0.06 (-5.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Cash & Current Investments (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC (VRXA) reported Cash & Current Investments of $3.41 million for the quarter ended Dec 31, 2025, down 45.8% from $6.3 million a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Cash & Current Investments (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Veraxa Biotech AG - Post de-SPAC posted Cash & Current Investments of $3.29 million, down 47.6% from the prior year.

  • By year, Cash & Current Investments came in at $6.27 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Veraxa Biotech AG - Post de-SPAC 16.36 Mn 12.95 Mn - 3.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.41 Mn
Dec 31, 2024 6.30 Mn
API Access

Veraxa Biotech AG - Post de-SPAC Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VRXA&period=max&api_key=YOUR_API_KEY